In two distinct studies, Rasmussen et al. also successfully established iPSCs from skin fibroblasts of patients diagnosed with FTD carrying R406W and P301L mutations in MAPT to study hereditary FTD and tau pathologies in vitro [136,137]. This evidence concerns the gene MAPT and frontotemporal dementia.